CPT Code 52287 is the procedure code for cystourethroscopy with injection(s) for chemodenervation of the bladder. A urologist reports it after injecting botulinum toxin through a cystoscope into the detrusor muscle. The two covered indications are overactive bladder and neurogenic detrusor overactivity.
Every claim also carries HCPCS J0585 for the drug itself. Medicare’s 2026 national average pays $363.74 in the office and $148.97 in a facility. Missing documentation of failed conservative therapy is the most common reason the claim is denied.
Below are the fee schedule, the ICD-10 pairings, the modifier rules, and the documentation checklist that keeps claims clean.
Key takeaways
CPT Code 52287 covers cystourethroscopy with chemodenervation of the bladder by botulinum toxin injection, distinct from the head and neck codes 64615 and 64612.
J0585 (onabotulinumtoxinA, 1 unit) must be billed alongside CPT Code 52287 on every claim, and the units must match the documented dose.
Medicare requires documented failure of conservative therapy, meaning an anticholinergic or a beta-3 agonist, before the procedure counts as medically necessary.
The 2026 Medicare national average pays $363.74 in the office setting and $148.97 in a facility, on a work RVU of 3.12.
Practice management software like Pabau pairs the codes automatically and flags a missing diagnosis code before the claim is submitted.
CPT Code 52287: Full descriptor and clinical definition
CPT Code 52287 is a surgical procedure code in the Urethra and Bladder (Transurethral) section of the AMA CPT code set. The official descriptor reads: Cystourethroscopy, with injection(s) for chemodenervation of the bladder.
In clinical terms, the urologist passes a cystoscope through the urethra. Botulinum toxin is then injected into the detrusor muscle at several sites along the bladder wall. The toxin temporarily inhibits acetylcholine release at the neuromuscular junction, which reduces involuntary detrusor contractions.
FDA-approved dosing is 100 units of onabotulinumtoxinA for overactive bladder (OAB). Neurogenic detrusor overactivity (NDO) caused by spinal cord injury or multiple sclerosis takes 200 units.
ICD-10 codes that support medical necessity
Every claim for CPT Code 52287 requires a supporting diagnosis code. Medicare’s coverage articles DA59714 and A52848 specify which ICD-10-CM codes satisfy medical necessity.
A non-listed code is one of the fastest routes to an automatic denial, so confirm the selection before submission rather than after. You can cross-reference pairings using the AAPC CPT-to-ICD-10 crosswalk or check a MAC’s LCD directly.
Off-label indications such as bladder pain syndrome and interstitial cystitis are not covered by Medicare under CPT Code 52287. Confirm the diagnosis sits on the covered list before the service date, not after the denial arrives.
Companion code: Billing HCPCS J0585 with the procedure
J0585 is the HCPCS Level II drug code for onabotulinumtoxinA (Botox), billed at 1 unit per 1 unit of drug administered. It is reported on the same claim as CPT Code 52287. The quantity must match the exact dose documented in the operative note.
According to CMS HCPCS guidelines, J0585 is billed per unit administered rather than per vial purchased. Practices that bill for a full 200-unit vial when only 100 units were administered are creating a compliance exposure.
- OAB indication: typically 100 units total; bill J0585 x 100 units
- NDO indication (spinal cord injury or MS): typically 200 units total; bill J0585 x 200 units
- Drug wastage: if a vial holds more than the administered dose, document the waste and bill only administered units. Check your MAC’s LCD for wastage rules before billing unused portions.
- Same-claim requirement: J0585 and CPT Code 52287 must appear on the same claim. Splitting them across dates of service denies the drug code automatically.
The diagnosis, the dose, and the J0585 unit count all move together with the indication. The comparison below lines both versions of the claim up side by side.

Practices that submit claims through Claim.MD, Pabau’s integrated US clearinghouse, can automate the pairing. J0585 is attached whenever 52287 is scheduled, so billing staff never have to check it by hand.
Medicare reimbursement rates for CPT Code 52287
Medicare reimburses CPT Code 52287 under the Medicare Physician Fee Schedule (MPFS). The rates below are national averages, before any Geographic Practice Cost Index (GPCI) adjustment. Your payment varies by location, so check the CMS MPFS lookup tool for a location-specific figure.
Use the FastRVU 2026 RVU lookup to pull the Work, Practice Expense, and Malpractice RVU breakdown for 52287 at your own location. The place of service on the claim decides which of the two figures applies, so an incorrect POS changes what you are paid.
Facility vs non-facility place of service rates
CMS assumes the practice carries the overhead in an office setting, so the non-facility rate is higher. In a facility, the hospital or ASC bills CMS separately for its own costs, and the physician payment drops to match.
When you decide where to perform bladder chemodenervation, weigh the whole reimbursement event rather than the physician line alone. Depending on your contract mix, one site of service may favor the practice over the other.
Which modifiers apply, and when
Modifier selection for CPT Code 52287 depends on the clinical circumstances. The wrong modifier is a common denial trigger, especially in bilateral or reduced-service scenarios. Verify modifier applicability against the current CMS MPFS modifier indicators before submitting.
Modifier 22 (increased procedural services) may fit when the documentation supports substantially greater effort than usual. Attach a detailed operative note every time you use it.
Pro Tip
Run a pre-submission edit check on every 52287 claim. Confirm that the J0585 units match the administered dose. Check that the ICD-10 code sits on the MAC’s covered list, and that the place of service matches where the procedure happened. Those three checks catch the denial patterns this code attracts most often.
Medicare and payer coverage criteria
Medicare covers CPT Code 52287 for overactive bladder and neurogenic detrusor overactivity under CMS billing articles DA59714 and A52848. Local coverage determinations (LCDs) issued by Medicare Administrative Contractors govern the detail.
Always read your own MAC’s LCD, because what applies in one jurisdiction may not apply in another. Verifying the patient’s benefits before the procedure date confirms coverage under their specific plan.
Documentation requirements for medical necessity
CMS expects the following elements to establish medical necessity for CPT Code 52287. Missing any one of them is grounds for denial on audit or pre-payment review.
- Confirmed diagnosis: a documented diagnosis of OAB (N32.81) or NDO (N31.9, with the underlying neurological condition) in the medical record
- Failed conservative therapy: a documented trial and failure of at least one anticholinergic or beta-3 agonist (e.g. oxybutynin, mirabegron) at an adequate dose and duration
- Urodynamic study results: for NDO cases, urodynamic confirmation of detrusor overactivity is required by most MACs
- Informed consent: signed consent covering procedure risks, anticipated repeat treatment intervals, and self-catheterization requirements
- FDA-approved indication: documentation that the indication is FDA-approved, meaning OAB or NDO related to spinal cord injury or MS. Off-label use needs separate justification and is generally not covered.
Capture the diagnosis, the procedure code, the drug code, and the administered units before the patient leaves the facility. Building that step into the standard procedure checkout stops the billing team reconstructing the note days later.
Related codes in the chemodenervation family
Knowing the code family around CPT Code 52287 prevents both under-coding and over-coding. The table below covers the adjacent codes that urology and chemodenervation billing teams confuse most often.
A separate endoscopic procedure at the same encounter, such as a cystoscopy for biopsy, changes the coding. Modifier 59 on the secondary code may be necessary. Check the NCCI edits for that code pair before you submit.
Common billing errors and denial reasons
These are the denial patterns urology billing teams hit most often on this code, drawn from CMS audit guidance and MAC LCD policy requirements.
- Missing J0585 on the claim: 52287 without J0585 attached leaves the drug cost unbillable. Most practices catch this at the clearinghouse, but it still creates rework. Automate the pairing at the scheduling or superbill stage.
- J0585 unit count mismatch: the operative note says 150 units administered and the claim says 200. Payers audit high-unit claims for 52287 because the drug is expensive, so the note must match the billed quantity exactly.
- No documentation of failed conservative therapy: this is the single most common denial reason cited in MAC LCDs. The chart needs the drug name, the dose, the duration, and the reason for discontinuation.
- Incorrect ICD-10 code: a non-covered diagnosis such as N30.10 (cystitis without hematuria) in place of N32.81 draws an automatic medical necessity denial. Cross-check against the MAC’s covered-diagnosis list before service.
- Place-of-service mismatch: the claim states POS 11 (office) but the procedure happened at an ASC (POS 24). That triggers a reimbursement differential discrepancy and may generate a recoupment.
- Thin operative reporting: 52000 is bundled and not separately billable, but the report still has to document the cystoscopic visualization and the injection technique. A bare assertion that the procedure was performed will not survive an audit.
Effective denial management for 52287 starts before the claim goes out. A pre-submission checklist inside the billing workflow catches most of these errors without a separate audit step. Tracking which reason codes recur also tells you whether the problem is systemic or a one-off.
How Pabau automates the 52287 claim build
Urology practices billing this code repeatedly hit the same friction. Someone attaches J0585 by hand, checks the ICD-10 against the MAC’s covered list, and hunts for the note proving conservative therapy failed. Every one of those steps is a manual touchpoint where errors compound.
Practice management software like Pabau handles those touchpoints in one system. Pabau’s claims management software lets you configure default code pairings. Every 52287 appointment then generates the J0585 line, with the unit quantity taken from the clinical note. Update the administered units in the patient record and the billing line updates with them.

Documentation templates built around the CMS medical necessity checklist capture failed conservative therapy at the visit where it happens, not at the billing stage. Pabau also flags claims where the appointment’s place of service differs from the billing record, so POS mismatches surface before the 837 file is generated.
Billing for urology procedures shouldn’t slow down your practice
Pabau connects scheduling, clinical documentation, and claims management in one system, so urology teams spend less time chasing paperwork and more time with patients.
Conclusion
Two habits decide whether 52287 pays cleanly. Pair the drug code with the procedure at the point of care. Record the failed conservative therapy while the patient is still in front of you. Fix both upstream and the claim stops coming back.
The trade-off worth remembering is the site of service. The office rate is more than double the facility rate, but the practice absorbs the overhead that earns it. Model both before you move the procedure.
Book a demo to see how Pabau builds a 52287 claim, drug line included, straight from the urology operative note.
Continue your research
Need to understand how clearinghouse claim submission works end to end? Medical claims clearinghouse guide explains the full submission pathway from practice to payer.
Struggling with 837 file errors on urology claims? Electronic 837 claim file breaks down the format requirements and common rejection reasons.
Want to benchmark your denial rate against industry norms? Denial codes in medical billing covers the CARC and RARC codes you’ll see on remittances for procedure code denials.
Want the drug units captured before the patient leaves? What a superbill is shows which fields to capture at checkout so the claim builds itself.
Paid less than the fee schedule says you should be? Electronic remittance advice explains how to read the ERA and spot an underpayment early.
Frequently asked questions
What is CPT Code 52287 used for?
CPT Code 52287 reports cystourethroscopy with injection(s) for chemodenervation of the bladder. That means the transurethral injection of botulinum toxin into the detrusor muscle to treat overactive bladder or neurogenic detrusor overactivity. It is an endoscopic surgical procedure performed by urologists and billed alongside HCPCS J0585 for the drug cost.
Does Medicare cover bladder Botox injections under CPT 52287?
Yes, Medicare covers CPT Code 52287 for the FDA-approved indications: overactive bladder (N32.81) and neurogenic detrusor overactivity related to spinal cord injury or multiple sclerosis. Coverage requires documented failure of conservative treatment, meaning an anticholinergic or a beta-3 agonist. Your MAC’s local coverage determination may impose further requirements beyond the national CMS articles DA59714 and A52848.
Is CPT 52287 billed with J0585, and how many units?
Yes, J0585 (onabotulinumtoxinA, 1 unit per unit of drug) must appear on the same claim as CPT Code 52287. Bill J0585 x 100 units for the OAB indication and x 200 units for neurogenic detrusor overactivity. The billed quantity must match the administered dose documented in the operative note, because overbilling unused units is a compliance violation.
What modifiers apply to CPT Code 52287?
Modifier 52 (reduced services) applies when fewer injection sites were used due to patient tolerance. Modifier 59 applies when 52287 is performed alongside a separate, distinct procedure on the same day. Modifier 51 goes on the secondary procedure when multiple procedures are billed together. Modifier 50 (bilateral) is not typically applicable to bladder chemodenervation, so confirm with your MAC before using it.
What is the difference between facility and non-facility rates for CPT 52287?
The non-facility (office) rate is higher for the physician, about $364 at the 2026 national average, because the practice absorbs the overhead. The facility rate for a hospital or ASC is about $149, because the facility bills CMS separately for its own costs. Total reimbursement into the system is similar, but the physician’s portion differs by site of service.
What ICD-10 codes are used with CPT 52287?
The primary ICD-10-CM codes used with CPT Code 52287 are N32.81 (overactive bladder), N31.9 (neuromuscular dysfunction of bladder), and N39.41 (urge incontinence). For neurogenic cases, G35 (multiple sclerosis) or G82.20 (paraplegia) may be added as secondary codes. Always verify the full covered-diagnosis list against your MAC’s LCD before service.